Search Results
What are the newer options for patients who fail first- and second-generation TKI therapies?
What are the major reasons why patients fail to respond to TKI therapies?
Strategies in Chronic Myeloid Leukemia: The Evolving Treatment Landscape
Selecting optimal treatment for patients with chronic myeloid leukaemia after prior lines of therapy
First and Second Generation ALK Inhibitors for the Treatment of Lung Cancer
Recent advances in diagnosis & management of Chronic myeloid leukemia (CML) | AFAHD
Treating the Newly Diagnosed Patient With Chronic Myeloid Leukemia
Global Perspectives | Evolution of CML Treatment and Managing Adverse Events
Meet the Expert on Cancer Treatment updates - 16 Nov 2024
Faster, Better, Safer—Getting CML Treatment Right
Second-Generation Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia
UPFRONT 2ND GENERATION TKI FOR NEWLY DIAGNOSED CHRONIC PHASE CML? QIAN JIANG
